Attached files
| file | filename |
|---|---|
| 10-K - Pathfinder Cell Therapy, Inc. | v178047_10k.htm |
| EX-31.1 - Pathfinder Cell Therapy, Inc. | v178047_ex31-1.htm |
| EX-32.1 - Pathfinder Cell Therapy, Inc. | v178047_ex32-1.htm |
| EX-10.11 - Pathfinder Cell Therapy, Inc. | v178047_ex10-11.htm |
EXHIBIT
23.1
CONSENT
OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby
consent to the incorporation by reference in the Registration Statements on Form
S-3 (Nos. 333-147184, 333-146493 and 333-19195) and Form S-8 (Registration
Nos. 33-60580, 333-03895,
333-95127, 333-95129, 333-91386 and 333-134608) of SyntheMed, Inc. (the
"Company") of our report (which included an explanatory paragraph relating to
the Company's ability to continue as a going concern) dated March 19, 2010
relating to the financial statements, which appears in this Form
10-K.
/s/
EISNER LLP
New York,
New York
March 19,
2010